The new “pressurized olfactory device,” currently being tested on animals, is a noninvasive approach that could relieve pain with fewer side effects and faster onset of action.
Researchers at the University of Washington have used the device to deliver morphine with pinpoint precision directly to the olfactory region of the nasal cavity.
Related Articles on Pain Medications:
8 Pain Medication Mistakes Patients Make
Global Pain Medication Sales Rise 8.9% Since 2005
Study: Addiction to Meds Common for Chronic Pain Patients
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.